The Role of Biomarkers in the Occurrence and Development of Asthma
Recruiting · NCT05768399 · Observational (researchers observe without assigning treatment) · Lead sponsor: Children's Hospital of Chongqing Medical University
View the official record on ClinicalTrials.gov →Interventions studied
The level of biomarkers in Peripheral blood
What this trial is about
To study the expression level of biomarkers such as GITRL in peripheral blood of children with asthma and analyze their correlation with the severity of asthma. To study the predictive value of biomarkers level for the occurrence and development of asthma. And to provide supplementary detection means and predictive indicators for the diagnosis of asthma and the severity of asthma.
Who can take part
Age range
4 Years to 12 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- In line with the diagnostic criteria in the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children (2016 Edition)
- Age: 4-12 years old for new diagnosis or recurrent episodes
- Typical clinical manifestations and complete clinical data
- Family members or guardians of children with informed research and signed consent
- All healthy control subjects had no history of lung disease, allergic rhinitis or any other atopic disease
Exclusion criteria
- Suffering from other respiratory diseases (such as bronchiectasis, allergic rhinitis, respiratory failure, tuberculosis, obstructive airway disease) or other inflammatory diseases.
- Abnormal development of congenital airway and lung tissue
- History of immunosuppressant or glucocorticoid use in the first 4 weeks
- Suffering from other endocrine system and immune system diseases
- Incomplete clinical data or examinations.
Where it is running
1 location listed.
- Shaoqing Zhang - Chongqing, Chongqing Municipality, China